Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
lanadelumab plasma kallikrein biotech Successful target TTD , drugbank , DGIDB Disease[MeSHID:D004194]
Edema[MeSHID:D004487]
Angioedemas
Hereditary[MeSHID:D054179]
Mutation[MeSHID:D009154]
Limb structure[MeSHID:D005121]
Genitalia[MeSHID:D005835]
Larynx[MeSHID:D007830]
Pain[MeSHID:D010146]
Malnutrition[MeSHID:D044342]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 159.13 approved,investigational inhibitor
lanadelumab plasma kallikrein biotech Successful target TTD , drugbank , DGIDB Disease[MeSHID:D004194]
Edema[MeSHID:D004487]
Angioedemas
Hereditary[MeSHID:D054179]
Mutation[MeSHID:D009154]
Limb structure[MeSHID:D005121]
Genitalia[MeSHID:D005835]
Larynx[MeSHID:D007830]
Pain[MeSHID:D010146]
Malnutrition[MeSHID:D044342]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 159.13 approved,investigational inhibitor,antibody
click here to return to the previous page